 |
Previous Article | Next Article 
The Journal of Neuroscience, March 15, 2003, 23(6):2453
A Critical Role for the Cannabinoid CB1 Receptors in
Alcohol Dependence and Stress-Stimulated Ethanol Drinking
Ildiko
Racz1,
Andras
Bilkei-Gorzo1,
Zsuzsanna E.
Toth2,
Kerstin
Michel1,
Miklós
Palkovits2, and
Andreas
Zimmer1
1 Laboratory of Molecular Neurobiology, Department of
Psychiatry, University of Bonn, 53105 Bonn, Germany, and
2 SE Laboratory: Laboratory of Neuromorphology, Department
of Anatomy, Faculty of Medicine, Semmelweis University, 1094 Budapest
Tüzolto u.58., Hungary
Although many people drink alcohol regularly, only some become
addicted. Several studies have shown that genetic and environmental factors contribute to individual differences in the vulnerability to
the effects of alcohol (Nestler, 2000; Kreek, 2001; Crabbe, 2002).
Among the environmental factors, stress is perhaps the most important
trigger for relapse after a period of abstinence (Koob and Nestler,
1997; Piazza and Le Moal, 1998; Koob and Le Moal, 2001; Weiss et al.,
2001). Here we show that ethanol withdrawal symptoms were completely
absent in cannabinoid CB1 receptor-deficient mice, although
acute effects of ethanol and ethanol tolerance and preference were
basically normal. Furthermore, foot-shock stress had no affect on
alcohol preference in Cnr1 / mice, although it
induced a dramatic increase in Cnr1+/+ animals.
These results reveal a critical role for the CB1 receptor in clinically important aspects of alcohol dependence and provide a
rationale for the use of CB1 receptor antagonists in the
treatment of alcohol addiction.
Key words:
cannabinoid; ethanol; mice; mutation; withdrawal; addiction
Copyright © 2003 Society for Neuroscience 0270-6474/03/2362453-06$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
A. Mazur, C. F. Lichti, P. L. Prather, A. K. Zielinska, S. M. Bratton, A. Gallus-Zawada, M. Finel, G. P. Miller, A. Radominska-Pandya, and J. H. Moran
Characterization of Human Hepatic and Extrahepatic UDP-Glucuronosyltransferase Enzymes Involved in the Metabolism of Classic Cannabinoids
Drug Metab. Dispos.,
July 1, 2009;
37(7):
1496 - 1504.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. M. Newton, L. Zeng, V. Wang, J. Connolly, M. J. Wallace, C. Kim, H.-S. Shin, F. Belardetti, T. P. Snutch, and R. O. Messing
A Blocker of N- and T-type Voltage-Gated Calcium Channels Attenuates Ethanol-Induced Intoxication, Place Preference, Self-Administration, and Reinstatement
J. Neurosci.,
November 5, 2008;
28(45):
11712 - 11719.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Chen, V. S. Williamson, S.-S. An, J. M. Hettema, S. H. Aggen, M. C. Neale, and K. S. Kendler
Cannabinoid Receptor 1 Gene Association With Nicotine Dependence
Arch Gen Psychiatry,
July 1, 2008;
65(7):
816 - 823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Hutchison, H. Haughey, M. Niculescu, J. Schacht, A. Kaiser, J. Stitzel, W. J. Horton, and F. Filbey
The Incentive Salience of Alcohol: Translating the Effects of Genetic Variant in CNR1
Arch Gen Psychiatry,
July 1, 2008;
65(7):
841 - 850.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev.,
September 1, 2006;
58(3):
389 - 462.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Aharonovich, X. Liu, S. Samet, E. Nunes, R. Waxman, and D. Hasin
Postdischarge Cannabis Use and Its Relationship to Cocaine, Alcohol, and Heroin Use: A Prospective Study
Am J Psychiatry,
August 1, 2005;
162(8):
1507 - 1514.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Shoemaker, B. K. Joseph, M. B. Ruckle, P. R. Mayeux, and P. L. Prather
The Endocannabinoid Noladin Ether Acts as a Full Agonist at Human CB2 Cannabinoid Receptors
J. Pharmacol. Exp. Ther.,
August 1, 2005;
314(2):
868 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. LALLEMAND and P. De WITTE
ETHANOL INDUCES HIGHER BEC IN CB1 CANNABINOID RECEPTOR KNOCKOUT MICE WHILE DECREASING ETHANOL PREFERENCE
Alcohol Alcohol.,
January 1, 2005;
40(1):
54 - 62.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. L. GESSA, S. SERRA, G. VACCA, M. A. M. CARAI, and G. COLOMBO
SUPPRESSING EFFECT OF THE CANNABINOID CB1 RECEPTOR ANTAGONIST, SR147778, ON ALCOHOL INTAKE AND MOTIVATIONAL PROPERTIES OF ALCOHOL IN ALCOHOL-PREFERRING sP RATS
Alcohol Alcohol.,
January 1, 2005;
40(1):
46 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Y. Baskfield, B. R. Martin, and J. L. Wiley
Differential Effects of {Delta}9-Tetrahydrocannabinol and Methanandamide in CB1 Knockout and Wild-Type Mice
J. Pharmacol. Exp. Ther.,
April 1, 2004;
309(1):
86 - 91.
[Abstract]
[Full Text]
|
 |
|
|

|